Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-08

FDA Approved: IVABRADINE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Alembic Pharmaceuticals Limited's original application for a generic IVABRADINE product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVABRADINE

Snippet

ORIG AP for IVABRADINE (IVABRADINE)